Genscript Biotech plans spin-off and Hong Kong listing of Probio
Genscript Biotech plans a spin-off and a Hong Kong listing of its non-wholly-owned subsidiary Probio Technology.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.